Search
Coagulin-B
go.drugbank.com/drugs/DB17703Experimental[A259038, A259043] It was previously investigated for the treatment of hemophilia; however, the manufacturing company discontinued the Phase I trial in 2004, halting its further development and investigation
Mosapride
go.drugbank.com/drugs/DB11675InvestigationalMosapride has been investigated for the treatment and diagnostic of Constipation, Type 2 Diabetes, Functional Dyspepsia, Functional Constipation, and Epigastric Pain Syndrome, among others.
Colforsin
go.drugbank.com/drugs/DB02587InvestigationalHas antihypertensive, positive inotropic, platelet aggregation inhibitory, and smooth muscle relaxant activities; also lowers intraocular pressure and promotes release of hormones from the pituitary gland
Zonampanel anhydrous
go.drugbank.com/drugs/DB20448InvestigationalZonampanel anhydrous has a monoisotopic molecular weight of 331.06 Da.
Risovalisib
go.drugbank.com/drugs/DB21474InvestigationalRisovalisib has a monoisotopic molecular weight of 598.19 Da.
Retezorogant
go.drugbank.com/drugs/DB21592ExperimentalRetezorogant has a monoisotopic molecular weight of 420.22 Da.
Eladocagene exuparvovec
go.drugbank.com/drugs/DB16780ApprovedInvestigational[A253687] It was subsequently approved by the FDA in November 2024.[L51898,L51893]
Basifungin
go.drugbank.com/drugs/DB14058ExperimentalBasifungin, also known as _aureuobacidin A_, is a phosphorylceramide synthase inhibitor [L2960], [A33381].
CYNK-001
go.drugbank.com/drugs/DB15722InvestigationalCYNK-001 is a novel allogenic off-the-shelf natural killer (NK) cell therapy originating from human placental CD34+ hematopoietic stem cells and enriched with CD56+/CD3-.